SCHEMBL19009573

SCHEMBL19009573

Cc1ccc(-c2ccc(-c3nc(-c4ccc(-c5ccc(C)nc5)cc4)nc(-c4cccc(-c5ccc(-c6ccccc6)cc5)c4)n3)cc2)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
NFKB1 P19838 2/20 0.44
NFKB2 Q00653 2/20 0.44
RELA Q04206 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
ATM Q13315 1/20 0.43
PIK3CD O00329 1/20 0.42
PIK3CA P42336 1/20 0.42
PIK3CB P42338 1/20 0.42
PI4KA P42356 1/20 0.42
PIK3CG P48736 1/20 0.42
PI4KB Q9UBF8 1/20 0.42
PDGFRB P09619 1/20 0.42
PDGFRA P16234 1/20 0.42
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16189437 1.00 LMNA (0.47) LMNAL3MBTL1NPC1RAB9ANFKB1
SCHEMBL17532862 1.00 LMNA (0.47) LMNAL3MBTL1NPC1RAB9ANFKB1
SCHEMBL21982359 1.00 LMNA (0.47) LMNAL3MBTL1NPC1RAB9ANFKB1
SCHEMBL16189378 0.98 LMNA (0.49) LMNAL3MBTL1NPC1RAB9ANFKB1
SCHEMBL17532860 0.98 LMNA (0.49) LMNAL3MBTL1NPC1RAB9ANFKB1
SCHEMBL16189318 0.93 PIK3CD (0.46) LMNAL3MBTL1NPC1RAB9APIK3CD
SCHEMBL16189349 0.92 LMNA (0.49) LMNAL3MBTL1NPC1RAB9ANFKB1
SCHEMBL17532861 0.92 L3MBTL1 (0.55) LMNAL3MBTL1NPC1RAB9ANFKB1
SCHEMBL16189444 0.92 L3MBTL1 (0.55) LMNAL3MBTL1NPC1RAB9ANFKB1
SCHEMBL16189263 0.92 L3MBTL1 (0.55) LMNAL3MBTL1NPC1RAB9ANFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11329230-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-10 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed
US-20170179402-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11329230-B2 Organic light-emitting device EML4, SUN2, TRPA1 LMNA 2238/4885L3MBTL1 324/4885NPC1 317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.